Drugs / Xerovirinc
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01896609 | Jun 2013 → Jan 2015 | chronic hepatitis C virus infection | MinaPharm Pharmaceuticals | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xerovirinc | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01896609 ↗ |
| Route | Oral | “orally” NCT01896609 ↗ |